Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein
about
Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges.Atomoxetine: A Review of Its Pharmacokinetics and Pharmacogenomics Relative to Drug Disposition.In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder.An in vitro evaluation of guanfacine as a substrate for P-glycoprotein.Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2).
P2860
Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 October 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interactions of attention-defi ...... lux transporter P-glycoprotein
@en
Interactions of attention-defi ...... ux transporter P-glycoprotein.
@nl
type
label
Interactions of attention-defi ...... lux transporter P-glycoprotein
@en
Interactions of attention-defi ...... ux transporter P-glycoprotein.
@nl
prefLabel
Interactions of attention-defi ...... lux transporter P-glycoprotein
@en
Interactions of attention-defi ...... ux transporter P-glycoprotein.
@nl
P2093
P2860
P1476
Interactions of attention-defi ...... lux transporter P-glycoprotein
@en
P2093
Bryan B Gibson
C Lindsay DeVane
Hao-Jie Zhu
Jennifer L Donovan
John S Markowitz
Jun-Sheng Wang
P2860
P304
P356
10.1016/J.EJPHAR.2007.09.035
P407
P577
2007-10-05T00:00:00Z